Table 1 Main participants’ criteria
Participants’ criteria | Value | ||
|---|---|---|---|
Demographic criteria | |||
• Age (years) | Median (min–max) | 56.5 (42–75) | |
• Sex (Male) | Count (%) | 166 (65.9%) | |
Pre-intervention reserve liver functions | |||
• ALT (IU/L) | Median (min–max) | 39 (18–74) | |
• AST (IU/L) | Median (min–max) | 43 (20–81) | |
• s.albumin (gm/dl) | Median (min–max) | 3.4 (2.7–3.9) | |
• s.bilirubin (mg/dl) | Median (min–max) | 1.4 (0.9–1.9) | |
• Prothrombin concentration (%) | Median (min–max) | 71 (61–89) | |
Pre-interventional liver volumetric values and ratios | |||
• Liver volume (LV) (cm3) | Median (min–max) | 1714 (1011–3243) | |
• Tumor volume (TV) (cm3) | Median (min–max) | 383 (83–1269) | |
• Residual volume (RV) (cm3) | Median (min–max) | 1336 (827–2418) | |
• Residual to liver volumetric ratio (RLVR) | Median (min–max) | 0.7 (0.43–0.95) | |
Other evaluated clinical and laboratory parameters | |||
• Spleen diameter (cm) | Median (min–max) | 14 (10–20) | |
• s.creatinine (mg/dl) | Median (min–max) | 1.1 (0.8–1.3) | |
• Platelets (x103/mm3) | Median (min–max) | 149 (68–215) | |
• Child-Pugh score | A5 | Count (%) | 62 (24.6%) |
A6 | Count (%) | 102 (40.5%) | |
B7 | Count (%) | 85 (33.7%) | |
B8 | Count (%) | 3 (1.2%) | |
• AFP (ng/ml) | Median (min–max) | 129 (11–1245) | |
Post intervention measured criteria | |||
• Time to decompensation (week) | Median (min–max) | 6 (1–6) | |
• Hepatic decompensation | Decompensation | 82, 32.5% | |
No decompensation | 170, 68.5% | ||
Total | 252, 100% | ||